Foundations Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-193,036
| Closed | -$1.27M | – | 879 |
|
|
2024
Q3 | $1.27M | Buy |
193,036
+38,642
| +25% | +$255K | 0.03% | 327 |
|
|
2024
Q2 | $1.16M | Buy |
154,394
+115,418
| +296% | +$866K | 0.03% | 313 |
|
|
2024
Q1 | $389K | Sell |
38,976
-34,682
| -47% | -$346K | 0.01% | 520 |
|
|
2023
Q4 | $703K | Buy |
73,658
+51,551
| +233% | +$492K | 0.02% | 368 |
|
|
2023
Q3 | $169K | Sell |
22,107
-896
| -4% | -$6.85K | 0.01% | 620 |
|
|
2023
Q2 | $172K | Buy |
23,003
+1,842
| +9% | +$13.8K | 0.01% | 550 |
|
|
2023
Q1 | $141K | Buy |
21,161
+4,505
| +27% | +$30K | 0.01% | 495 |
|
|
2022
Q4 | $128K | Sell |
16,656
-5,051
| -23% | -$38.9K | 0.01% | 429 |
|
|
2022
Q3 | $231K | Sell |
21,707
-855
| -4% | -$9.1K | 0.01% | 355 |
|
|
2022
Q2 | $204K | Sell |
22,562
-962
| -4% | -$8.7K | 0.01% | 365 |
|
|
2022
Q1 | $175K | Buy |
23,524
+7,918
| +51% | +$58.9K | 0.01% | 337 |
|
|
2021
Q4 | $231K | Buy |
15,606
+5,359
| +52% | +$79.3K | 0.01% | 313 |
|
|
2021
Q3 | $219K | Buy |
10,247
+3,227
| +46% | +$69K | 0.01% | 286 |
|
|
2021
Q2 | $282K | Buy |
+7,020
| New | +$282K | 0.01% | 246 |
|